Evidence map›Paper›PMID 36428830›Full record

ReviewDiagnostics (Basel, Switzerland)2022

D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review.

Loris Wauthier, Julien Favresse, Michaël Hardy, Jonathan Douxfils, Grégoire Le Gal, Pierre-Marie Roy, Nick van Es, Cihan Ay, Hugo Ten Cate, Thierry Vander Borght and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Obesity Is a Thrombotic Risk Factor in Pregnant Women.Journal of clinical medicine · 2025
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 7 countries.

Loris WauthierDepartment of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium.ORCID 0000-0002-8937-8186
Julien FavresseDepartment of Laboratory Medicine, Clinique St-Luc Bouge, 5004 Namur, Belgium.
Michaël HardyNamur Thrombosis and Hemostasis Center (NTHC), CHU UCL Namur, Université Catholique de Louvain, 5530 Yvoir, Belgium.ORCID 0000-0001-6701-9417
Jonathan DouxfilsDepartment of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, 5000 Namur, Belgium.ORCID 0000-0002-7644-5298
Grégoire Le GalDepartment of Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.ORCID 0000-0002-9253-248X
Pierre-Marie RoyDepartment of Emergency Medicine, CHU Angers, Institut MITOVASC, Equipe CARME, UMR CNRS 6015-INSERM 1083, UNIV Angers, F-CRIN INNOVTE, 49000 Angers, France.
Nick van EsAmsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam UMC Location Universiteit van Amsterdam, 1105 Amsterdam, The Netherlands.ORCID 0000-0001-5256-6346
Cihan AyClinicial Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0003-2607-9717
Hugo Ten CateDepartment of Internal Medicine and Thrombosis Expertise Center, CARIM School for Cardiovascular Diseases, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.ORCID 0000-0001-7796-4463
Thierry Vander BorghtDepartment of Nuclear Medicine, CHU UCL Namur, 5530 Yvoir, Belgium.
Michaël V DupontDepartment of Radiology, CHU UCL Namur, 5530 Yvoir, Belgium.
Thomas LecompteDepartment of Pharmacy, Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, 5000 Namur, Belgium.
Giuseppe LippiSection of Clinical Biochemistry, University Hospital of Verona, 37134 Verona, Italy.ORCID 0000-0001-9523-9054
François MullierNamur Thrombosis and Hemostasis Center (NTHC), CHU UCL Namur, Université Catholique de Louvain, 5530 Yvoir, Belgium.ORCID 0000-0001-6947-6099
University of Namur · BEUCLouvain · BEAmsterdam University Medical Centers · NLCentre National de la Recherche Scientifique · FRCHU Dinant Godinne UCL Namur · BEClinique Saint-Joseph · BEJohannes Gutenberg University Mainz · DEMedical University of Vienna · ATUniversity of Ottawa · CAUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis, which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis (DVT) combined with a clinical pretest probability assessment. The intended use of the tests depends largely on the assay used, and local guidance should be applied. D-dimer testing may suffer from diagnostic errors occurring throughout the pre-analytical, analytical, and post-analytical phases of the testing process. This review aims to provide an overview of D-dimer testing and its value in diagnosing PE and discusses the variables that may impact the quality of its laboratory assessment.

Indexed as

analyticalD-dimerIn Vitro Diagnostic RegulationISO15189post-analyticalpre-analyticalpulmonary embolismvenous thromboembolism

Identifiers

PMID36428830
PMCPMC9689068
OpenAlexW4308909301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.